bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases
http://clinicaltrials.gov/ct2/show/NCT04748588
 
Apr 19, 2023
 
Prev Next